An Antiserum Containg Antibodies Directed Against Peptides Capable of Eliciting Protective Immunity Against toxic Shock Induced By Pyrogenic Exotoxins and Or of Antagonizing toxin Mediated Activation of T Cells
April 14, 2022
Medint, in partnership with Yissum, invites you to join esteemed speakers
Tanya Attias, Co-founder and CEO of Medint; Avital Beck. CEO of Wilk (TLV: WILK).
Dr. Ofra Beny, professor at The Hebrew University of Jerusalem and head of the Nanomedicine Laboratory, and
Oranit Ido 🇮🇱 - Executive Director of Future of Health (FOH).